Veri Medtech Holdings, Inc. is a healthcare technology company that operates digital health platforms specializing in alternative medicine, personalized diagnostics, and direct-to-consumer wellness solutions. The company delivers a vertically integrated telehealth ecosystem designed to connect patients with licensed healthcare professionals across the United States. Its core offerings and service lines are structured through its wholly owned operating subsidiaries: Veriheal, Inc., which operates a proprietary telehealth platform facilitating patient-physician consultations, medical cannabis evaluations, state certification and recommendation processing, individualized treatment guidance, and digital cannabis education resources; DosePop, Inc., a direct-to-consumer digital wellness platform that provides asynchronous and synchronous telehealth consultations, personalized compounded and commercially available prescription medications, and recurring subscription delivery across therapeutic categories such as medical weight management, dermatology, attention-deficit/hyperactivity disorder (ADHD), longevity and anti-aging, mental wellness, and sexual health; and Alternative Medical Clinic LLC, which provides clinical practice management and physician network coordination. The company supports its service delivery through a proprietary software infrastructure that integrates electronic medical records, automated patient-physician matching, compliance workflows, and digital fulfillment logistics. Veri Medtech Holdings primarily targets adult consumer patients seeking accessible, non-stigmatized alternative therapies and prescription wellness care, operating across legally authorized state jurisdictions in the United States. The company was founded in 2017 and is headquartered in McLean, Virginia. Formerly known as Light Media Holdings, Inc., the company completed a major corporate reorganization and rebranding to Veri Medtech Holdings, Inc. to consolidate its digital health operations. In recent corporate developments, the company expanded its commercial scope beyond medical cannabis consultations through the rollout of its DosePop wellness brand; surpassed $100 million in cumulative platform sales revenue since inception; and filed a Form S-1 registration statement with the U.S. Securities and Exchange Commission to conduct a public offering and uplist its common stock from the OTC Markets to the Nasdaq Capital Market under the ticker symbol VRHI.